Archive for February 2023
Massachusetts is home to the fastest-growing startup city. It’s not Boston.
Huge funding rounds from Form Energy and Flagship-backed Cellarity sent this Massachusetts city to the top of the fastest-growing startup city list. Read More
Read MoreFive things you need to know today, and is data science really a science?
Here are five things you need to know today, and a trip back to my alma mater, BU, from a couple weeks ago, when I actually learned something new. Read More
Read MoreA ‘trade-secret case with no secrets:’ Pega lays out appeal in $2B Appian case
"The largest judgment in Virginia history is so riddled with legal error that it has all the structural integrity of a skyscraper of cards," is the opening of Pega’s appeal brief. Read More
Read MoreJudge in whistleblower lawsuit against MIT hears pre-trial arguments
A Superior Court judge indicated this week that he’s inclined to allow more wide-ranging depositions to take place than MIT would prefer in a lawsuit brought by a former researcher on the now-defunct OpenAg project. Read More
Read MoreVertex has built a CF empire. Next up: cell and gene therapy.
The pharmaceutical giant’s next play is a CRISPR-based gene therapy that could launch as soon as this year. Read More
Read MoreUMass Chan Medical School rebrands its consulting firm
ForHealth Consulting, formerly called Commonwealth Medicine, brought in $200 million in revenue for UMass Chan in fiscal 2022. Read More
Read MoreGoogle’s $300M AI bet, startup tackles long Covid, and giving computers a ‘sense of smell’
In the latest National Beat, we detail Google’s latest AI moves, run down some startups to watch, and introduce you to the viral Phoenix startup hat makes enormous hats. Read More
Read MoreAttorneys clash over FTX fallout lawsuits involving Tom Brady, David Ortiz
Tom Brady, David Ortiz and other celebs face multiple lawsuits after starring in ads for failed crypto exchange FTX. Read More
Read MoreStem cell startup raises $62M amid ‘difficult economic environment’
Fifteen months after launching with $72 million and a mission to treat 70 different diseases with stem cell-based drugs, Garuda Therapeutics is compounding on its success, raising $62 million and looking at 120 potential target diseases. Read More
Read MoreNew grant funding will help nonprofits create pathways for youth
“Students are coming here because the traditional world wasn’t working for them in a million different ways,” said Catherine Gobron, the co-founder and executive director at LightHouse. Read More
Read More